{"schema_version":"secwatch.filing_event.v1","accession":"0001386570-25-000030","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2025-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.279282+00:00","generated_at":"2026-05-16T12:24:10.663403+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Niagen acquires QUB NR patent portfolio; $1M upfront, annual payments through 2038","bullets":["One-time ~$1M payment to QUB for accrued royalties through 2024; annual $500K+£35K through 2038.","Additional one-time payments of $1.5M in 2035 and $2M in 2038 as consideration for patent assignment and release.","QUB assigned all patent rights to ChromaDex; prior JOMA and License Agreement terminated with royalty obligations released.","Acquired portfolio includes composition-of-matter patents for NR salt forms (e.g., NR Malate, NR Tartrate) and global rights.","Niagen now sole owner of core NR IP estate with >90 patents worldwide; CEO cites enhanced control and shareholder protection."],"urls":{"canonical":"https://secwatch.observer/filing/0001386570-25-000030","json":"https://secwatch.observer/filing/0001386570-25-000030.json","markdown":"https://secwatch.observer/filing/0001386570-25-000030.md","text":"https://secwatch.observer/filing/0001386570-25-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000138657025000030/0001386570-25-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000138657025000030/cdxc-20251218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:24:10.663403+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}